跳至主要内容
临床试验/NCT01220791
NCT01220791Unknown4 期

Methylprednisolone vs. Placebo to Control Late Follicular Progesterone Elevation in GnRH-Antagonist IVF Cycles

Universitair Ziekenhuis Brussel2 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
4 期
入组人数
130
试验地点
2
主要终点
Progesterone rise above 1.5ng.ml on the day of HCG

研究概览

简要总结

Hypothesis to be tested is whether follicular addition of Methylprednisolone can efficiently control late follicular progesterone rise during IVF treatment

详细描述

The aim is to investigate any potential advantages of adding cortisone supplementation from the follicular phase onwards with regard to premature luteinization, oocyte quality, embryo quality and pregnancy outcome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
21 Years 至 36 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • less than 36, more than 10 antral follicles, FSH<12

排除标准

  • endometriosis stage III&IV,

结局指标

主要结局

Progesterone rise above 1.5ng.ml on the day of HCG

时间窗: up to 14 days of follicular ovarian stimulation

Incidence or high progesterone on the day of HCG triggering

次要结局

  • Clinical pregnancy rate(Follow pregnancy until delivery)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验